CCEP Stock Analysis: Coca-Cola European | NASDAQ
Beverages - Non-Alcoholic | NASDAQ, USA | Market Cap: 43.947m USD | 12M Return: 16.8% | GB00BDCPN049 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 169M
EPS Trend: -34.8%
Qual. Beats: 0
Rev. Trend: 93.4%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Coca-Cola Europacific Partners PLC (NASDAQ: CCEP) is a UK-headquartered producer, distributor, and seller of non-alcoholic ready-to-drink beverages. Its product portfolio spans flavours, mixers, energy drinks, soft drinks, water, enhanced water, isotonic drinks, tea and coffee, juices, and other beverages, marketed under a broad brand roster that includes Coca-Cola Original Taste, Coca-Cola Zero Sugar, Diet Coke, Sprite, Fanta, Monster Energy, Dr Pepper, Schweppes, smartwater, Minute Maid, and Jack Daniels & Coca-Cola ready-to-drink, among many others. The company also conducts bottling and related operations.
The company was founded in 1904 and is based in Uxbridge, United Kingdom. It was renamed Coca-Cola Europacific Partners PLC in May 2021, having previously operated as Coca-Cola European Partners plc. CCEP is classified within the GICS Consumer Staples sector, specifically the Soft Drinks & Non-alcoholic Beverages sub-industry, and is listed as a large-cap common stock.
CCEP operates as a licensed bottler-distributor under The Coca-Cola Companys franchise system, where concentrate production and brand marketing are concentrated at the brand owner and bottlers such as CCEP handle manufacturing, packaging, and route-to-market activities across their territories. The 2021 rebranding coincided with the acquisition of Coca-Cola Amatil, which extended CCEPs footprint from Europe into the Asia-Pacific region, broadening its geographic scope beyond the European Union, Great Britain, and Norway.
- EUR and AUD FX translation headwinds pressure reported revenue growth
- Input cost inflation on aluminum and sweeteners compresses gross margins
- Coca-Cola Amatil acquisition expands Asia-Pacific footprint and volume base
| Net Income: 2.00b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.36 > 1.0 |
| NWC/Revenue: -4.87% < 20% (prev -7.71%; Δ 2.84% < -1%) |
| CFO/TA 0.09 > 3% & CFO 2.85b > Net Income 2.00b |
| Net Debt (10.9b) to EBITDA (3.58b): 3.04 < 3 |
| Current Ratio: 0.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (446.0m) vs 12m ago -3.04% < -2% |
| Gross Margin: 35.56% > 18% (prev 35.46%; Δ 0.10% > 0.5%) |
| Asset Turnover: 66.46% > 50% (prev 65.70%; Δ 0.76% > 0%) |
| Interest Coverage Ratio: 9.18 > 6 (EBIT TTM 2.94b / Interest Expense TTM 320.7m) |
| A: -0.03 (Total Current Assets 8.32b - Total Current Liabilities 9.36b) / Total Assets 32.5b |
| B: 0.28 (Retained Earnings 9.22b / Total Assets 32.5b) |
| C: 0.09 (EBIT TTM 2.94b / Avg Total Assets 32.1b) |
| D: 0.35 (Book Value of Equity 8.27b / Total Liabilities 23.7b) |
| Altman-Z'' = 1.70 = BB |
| DSRI: 1.03 (Receivables 3.54b/3.35b, Revenue 21.4b/20.9b) |
| GMI: 1.00 (GM 35.46% / 35.56%) |
| AQI: 1.00 (AQ_t 0.55 / AQ_t-1 0.55) |
| SGI: 1.02 (Revenue 21.4b / 20.9b) |
| TATA: -0.03 (NI 2.00b - CFO 2.85b) / TA 32.5b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at USD 101.73 with a total of 1,253,403 shares traded. Over the past week, the price has changed by +1.96%, over one month by -7.39%, over three months by +2.14% and over the past year by +16.80%.
Current recommended Stop Loss: 97.30 (which is 4.4% or 2.1 ATR below the current price).
Coca-Cola European has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CCEP.
- StrongBuy: 7
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 110.3 | 8.4% |
Market Cap EUR = 38.6b (43.9b USD * 0.87914001941681 USD.EUR)
P/E Trailing = 19.6012
P/E Forward = 17.9856
P/S = 2.0583
P/B = 4.6343
P/EG = 2.6517
Revenue TTM = 21.4b EUR
EBIT TTM = 2.94b EUR
EBITDA TTM = 3.58b EUR
Long Term Debt = 9.69b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.66b EUR (from shortTermDebt, last quarter)
Debt = 12.9b EUR (from shortLongTermDebtTotal, last quarter) + Leases 699.0m
Net Debt = 10.9b EUR (calculated: Debt 12.9b - CCE 1.99b)
Enterprise Value = 49.5b EUR (38.6b + Debt 12.9b - CCE 1.99b)
Interest Coverage Ratio = 9.18 (Ebit TTM 2.94b / Interest Expense TTM 320.7m)
EV/FCF = 23.45x (Enterprise Value 49.5b / FCF TTM 2.11b)
FCF Yield = 4.26% (FCF TTM 2.11b / Enterprise Value 49.5b)
FCF Margin = 9.89% (FCF TTM 2.11b / Revenue TTM 21.4b)
Net Margin = 9.35% (Net Income TTM 2.00b / Revenue TTM 21.4b)
Gross Margin = 35.56% ((Revenue TTM 21.4b - Cost of Revenue TTM 13.8b) / Revenue TTM)
Gross Margin QoQ = 35.32% (prev 35.81%)
Tobins Q-Ratio = 1.53 (Enterprise Value 49.5b / Total Assets 32.5b)
Interest Expense / Debt = 2.49% (Interest Expense 320.7m / Debt 12.9b)
Taxrate = 23.23% (615.0m / 2.65b)
NOPAT = 2.26b (EBIT 2.94b * (1 - 23.23%))
Current Ratio = 0.89 (Total Current Assets 8.32b / Total Current Liabilities 9.36b)
Debt / Equity = 1.56 (Debt 12.9b / totalStockholderEquity, last quarter 8.27b)
Debt / EBITDA = 3.04 (Net Debt 10.9b / EBITDA 3.58b)
Debt / FCF = 5.16 (Net Debt 10.9b / FCF TTM 2.11b)
Total Stockholder Equity = 8.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.21% (Net Income 2.00b / Total Assets 32.5b)
RoE = 24.47% (Net Income TTM 2.00b / Total Stockholder Equity 8.16b)
RoCE = 16.50% (EBIT 2.94b / Capital Employed (Equity 8.16b + L.T.Debt 9.69b))
RoIC = 9.54% (NOPAT 2.26b / Invested Capital 23.7b)
WACC = 5.08% (E(38.6b)/V(51.5b) * Re(6.14%) + D(12.9b)/V(51.5b) * Rd(2.49%) * (1-Tc(0.23)))
Discount Rate = 6.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -57.28 | Cagr: -1.17%
[DCF] Terminal Value 75.00% ; FCFF base≈2.14b ; Y1≈2.09b ; Y5≈2.10b
[DCF] Fair Price = 49.86 (EV 32.9b - Net Debt 10.9b = Equity 22.0b / Shares 440.5m; r=8.35% [WACC [floored]]; 5y FCF grow -3.16% → 2.50% )
EPS Correlation: -34.77 | EPS CAGR: -15.18% | SUE: 0.0 | # QB: 0
Revenue Correlation: 93.40 | Revenue CAGR: 6.86% | SUE: 2.02 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=4.49 | Chg30d=-0.11% | Revisions=+0% | GrowthEPS=+4.9% | GrowthRev=+3.3%
EPS next Year (2027-12-31): EPS=4.91 | Chg30d=-0.18% | Revisions=+40% | GrowthEPS=+9.2% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: +40% (up=2, down=0)